Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.
Total raised: $96.5M
Investors 1
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.01.2024 | Series C | $55M | - |
| 09.09.2022 | Series B | $41.5M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 23.01.2024 | Elephas Raises $55M in Series C Funding | Elephas, a Madison, WI-based company developing an ex-vivo platform to assess how live patient biops... | finsmes.co... |
| 07.09.2022 | Elephas Biosciences Raises $41.5M in Series B Funding | Elephas Biosciences Corporation, a Madison, Wis.-based oncology diagnostics company, raised $41.5m i... | finsmes.co... |
| 06.09.2022 | Elephas Biosciences Secures $41.5M Series B | MADISON, WI, Elephas Biosciences announced today that it has raised $41.5 million in Series B fund... | vcnewsdail... |
| - | Elephas Biosciences: Oncology Imaging Diagnostics Platform C... | Elephas Biosciences announced today that it has raised $55 million in Series C funding. Venture Inve... | pulse2.com... |